ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "BNT162b2"
BNT162b2
Publikace
Předměty
Osoby
Publikace
Studium
publication
Specific immune responses after BNT162b2 mRNA vaccination and COVID-19 infection
2023 |
1. lékařská fakulta
publication
SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers
2022 |
1. lékařská fakulta
publication
Response to Letter to the editor: Post-vaccination immunogenicity of BNT162b2 SARS-CoV-2 vaccine and its predictors in pediatric inflammatory bowel disease
2023 |
2. lékařská fakulta
publication
Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients
2022 |
1. lékařská fakulta, 2. lékařská fakulta
publication
Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
2021 |
1. lékařská fakulta, 2. lékařská fakulta
publication
SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients
2022 |
2. lékařská fakulta
publication
Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease
2023 |
2. lékařská fakulta
publication
Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs
2022 |
2. lékařská fakulta
publication
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
2022 |
3. lékařská fakulta
publication
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study
2022 |
1. lékařská fakulta, 2. lékařská fakulta, Fakulta tělesné výchovy a sportu
publication
Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency
2023 |
2. lékařská fakulta
publication
The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients
2023 |
3. lékařská fakulta, Ústřední knihovna
publication
Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial
2023 |
Lékařská fakulta v Plzni
publication
Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia
2022 |
Fakulta tělesné výchovy a sportu, 3. lékařská fakulta
publication
Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy
2022 |
2. lékařská fakulta
publication
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
2021 |
1. lékařská fakulta
publication
Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic
2022 |
Lékařská fakulta v Plzni
publication
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors
2021 |
2. lékařská fakulta
publication
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
2022 |
1. lékařská fakulta
publication
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study
2022 |
2. lékařská fakulta
publication
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
2022 |
Lékařská fakulta v Hradci Králové
publication
Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
2023 |
1. lékařská fakulta